Comparison of Kewaunee Scientific and Sanara MedTech Stock Metrics
1 report, 1 independent
Updated Oct 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kewaunee Scientific and Sanara MedTech are both classified as small-cap healthcare companies. A comparison of the two companies shows that Kewaunee Scientific has higher top-line revenue and earnings per share than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Kewaunee Scientific, suggesting it is currently more affordable.
From tickerreport.com
Why it matters
The companies show differing levels of institutional and insider ownership, with Kewaunee Scientific having higher institutional ownership (32.7%) than Sanara MedTech (8.1%). Furthermore, Sanara MedTech has a beta of 1.19, indicating its share price is 19% more volatile than the S&P 500, compared to Kewaunee Scientific's beta of 0.76.
From tickerreport.com